Pfizer's 2Q Financials Reveal Huge Drop In Covid Product Revenue; Comirnaty Down 82%, Paxlovid Down 98% From Year-Ago Quarter

By CT Centinal Staff

August 1, 2023

Connecticut's Premier Investigative Journalism

THE CONNECTICUT CENTINAL CDM

Newsletter MEET THE TEAM EDITORIAL GUIDELINES ADVERTISE WITH CDM PRIVACY POLICY ARTICLE SUBMISSIONS

[email protected]

Copyright © 2025 The Connecticut Centinal